CCAR2
Cell cycle and apoptosis regulator protein 2 · Q8N163 · CCAR2 on Sugi Atlas →
0 patent compounds predicted against CCAR2, 0 high-confidence (nearest known ligand ≥ 0.5)
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to CCAR2 by text similarity (a relevance ranking, not an exhaustive list)
Related proteins — ESM-2 sequence neighbours (a CCAR2 binder may also engage these)
| Protein | Name | Similarity | |
|---|---|---|---|
| Q5R8S0 | — | 1.000 | Q5R8S0 → |
| Q8VDP4 | — | 1.000 | Q8VDP4 → |
| Q3UJB9 | — | 0.991 | Q3UJB9 → |
| Q6PCQ0 | — | 0.991 | Q6PCQ0 → |
| Q9Z136 | — | 0.990 | Q9Z136 → |
| Q8N4X5 | — | 0.990 | Q8N4X5 → |
| Q6P9Q6 | — | 0.990 | Q6P9Q6 → |
| Q17R10 | — | 0.989 | Q17R10 → |
| NFRKB | Nuclear factor related to kappa-B-binding protein | 0.989 | landscape → |
| A0M8T5 | — | 0.989 | A0M8T5 → |
| Q8K330 | — | 0.989 | Q8K330 → |
| Q09YM8 | — | 0.989 | Q09YM8 → |
| Q80TQ5 | — | 0.989 | Q80TQ5 → |
| A1X157 | — | 0.989 | A1X157 → |
| Q76LL6 | — | 0.988 | Q76LL6 → |
| Q96ST8 | — | 0.988 | Q96ST8 → |
| Q9EP53 | — | 0.988 | Q9EP53 → |
| Q8IWE5 | — | 0.988 | Q8IWE5 → |
| Q09YJ3 | — | 0.988 | Q09YJ3 → |
| Q00PJ1 | — | 0.988 | Q00PJ1 → |
| Q3T1I9 | — | 0.988 | Q3T1I9 → |
| Q09YG9 | — | 0.987 | Q09YG9 → |
| A1A4J7 | — | 0.987 | A1A4J7 → |
| Q9CYA6 | — | 0.987 | Q9CYA6 → |
| Q2IBF8 | — | 0.987 | Q2IBF8 → |
| Q5T1M5 | — | 0.987 | Q5T1M5 → |
| Q2IBD4 | — | 0.987 | Q2IBD4 → |
| Q07E15 | — | 0.987 | Q07E15 → |
| Q09YK4 | — | 0.987 | Q09YK4 → |
| MAP3K9 | Mitogen-activated protein kinase kinase kinase 9 | 0.987 | landscape → |